BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27601142)

  • 21. Screening Mammography Performance Metrics of 2D Digital Mammography Versus Digital Breast Tomosynthesis in Women With a Personal History of Breast Cancer.
    Chikarmane SA; Cochon LR; Khorasani R; Sahu S; Giess CS
    AJR Am J Roentgenol; 2021 Sep; 217(3):587-594. PubMed ID: 32966113
    [No Abstract]   [Full Text] [Related]  

  • 22. Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study.
    Ro V; Jones T; Silverman T; McGuinness JE; Guzman A; Amenta J; Kukafka R; Crew KD
    BMC Cancer; 2022 Jul; 22(1):819. PubMed ID: 35897000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016.
    Lee JM; Ichikawa LE; Wernli KJ; Bowles E; Specht JM; Kerlikowske K; Miglioretti DL; Lowry KP; Tosteson ANA; Stout NK; Houssami N; Onega T; Buist DSM
    Radiology; 2021 Aug; 300(2):290-300. PubMed ID: 34003059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography.
    Ho TH; Bissell MCS; Kerlikowske K; Hubbard RA; Sprague BL; Lee CI; Tice JA; Tosteson ANA; Miglioretti DL
    JAMA Netw Open; 2022 Mar; 5(3):e222440. PubMed ID: 35333365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
    Miglioretti DL; Bissell MCS; Kerlikowske K; Buist DSM; Cummings SR; Henderson LM; Onega T; O'Meara ES; Rauscher GH; Sprague BL; Tosteson ANA; Wernli KJ; Lee JM; Lee CI
    JAMA Netw Open; 2021 Mar; 4(3):e211974. PubMed ID: 33764423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
    Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
    Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammography self-evaluation online test for screening readers: an Italian Society of Medical Radiology (SIRM) initiative.
    Brancato B; Peruzzi F; Saieva C; Schiaffino S; Catarzi S; Risso GG; Cozzi A; Carriero S; Calabrese M; Montemezzi S; Zuiani C; Sardanelli F
    Eur Radiol; 2022 Mar; 32(3):1624-1633. PubMed ID: 34480624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review.
    Robertson C; Ragupathy SK; Boachie C; Fraser C; Heys SD; Maclennan G; Mowatt G; Thomas RE; Gilbert FJ;
    Eur Radiol; 2011 Dec; 21(12):2484-91. PubMed ID: 21833567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Beneficial is Follow-Up Mammography in Elderly Breast Cancer Survivors?
    Massimino KP; Jochelson MS; Burgan IE; Stempel M; Morrow M
    Ann Surg Oncol; 2016 Oct; 23(11):3518-3523. PubMed ID: 27306905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of mammographic findings after breast-conserving therapy for carcinoma of the breast.
    Sardi A; Eckholdt G; McKinnon WM; Bolton JS
    Surg Gynecol Obstet; 1991 Oct; 173(4):309-12. PubMed ID: 1925902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women.
    ; Lewin AA; Moy L; Baron P; Didwania AD; diFlorio-Alexander RM; Hayward JH; Le-Petross HT; Newell MS; Rewari A; Scheel JR; Stuckey AR; Suh WW; Ulaner GA; Vincoff NS; Weinstein SP; Slanetz PJ
    J Am Coll Radiol; 2019 Nov; 16(11S):S428-S439. PubMed ID: 31685110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Under utilization of surveillance mammography among older breast cancer survivors.
    Field TS; Doubeni C; Fox MP; Buist DS; Wei F; Geiger AM; Quinn VP; Lash TL; Prout MN; Yood MU; Frost FJ; Silliman RA
    J Gen Intern Med; 2008 Feb; 23(2):158-63. PubMed ID: 18060463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density.
    ; Weinstein SP; Slanetz PJ; Lewin AA; Battaglia T; Chagpar AB; Dayaratna S; Dibble EH; Goel MS; Hayward JH; Kubicky CD; Le-Petross HT; Newell MS; Sanford MF; Scheel JR; Vincoff NS; Yao K; Moy L
    J Am Coll Radiol; 2021 Nov; 18(11S):S456-S473. PubMed ID: 34794600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACR Appropriateness Criteria
    ; Moy L; Bailey L; D'Orsi C; Green ED; Holbrook AI; Lee SJ; Lourenco AP; Mainiero MB; Sepulveda KA; Slanetz PJ; Trikha S; Yepes MM; Newell MS
    J Am Coll Radiol; 2017 May; 14(5S):S282-S292. PubMed ID: 28473085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prioritizing Screening Mammograms for Immediate Interpretation and Diagnostic Evaluation on the Basis of Risk for Recall.
    Ho TH; Bissell MCS; Lee CI; Lee JM; Sprague BL; Tosteson ANA; Wernli KJ; Henderson LM; Kerlikowske K; Miglioretti DL
    J Am Coll Radiol; 2023 Mar; 20(3):299-310. PubMed ID: 36273501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic Surveillance After Breast-Conserving Therapy: Impact of Digital Breast Tomosynthesis and Artificial Intelligence-Based Computer-Aided Detection.
    Yoon JH; Kim EK; Kim GR; Han K; Moon HJ
    AJR Am J Roentgenol; 2022 Jan; 218(1):42-51. PubMed ID: 34378399
    [No Abstract]   [Full Text] [Related]  

  • 39. Digital breast tomosynthesis plus synthesised mammography versus digital screening mammography for the detection of invasive breast cancer (TOSYMA): a multicentre, open-label, randomised, controlled, superiority trial.
    Heindel W; Weigel S; Gerß J; Hense HW; Sommer A; Krischke M; Kerschke L;
    Lancet Oncol; 2022 May; 23(5):601-611. PubMed ID: 35427470
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.